Anzeige
Mehr »
Mittwoch, 05.11.2025 - Börsentäglich über 12.000 News
SuperBuzz explodiert um 20% nach Mega-Deal mit NASDAQ-Werberiesen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DW24 | ISIN: SE0008091664 | Ticker-Symbol: 5LU
Frankfurt
05.11.25 | 08:04
0,003 Euro
0,00 % 0,000
1-Jahres-Chart
SIMRIS GROUP AB Chart 1 Jahr
5-Tage-Chart
SIMRIS GROUP AB 5-Tage-Chart

Aktuelle News zur SIMRIS GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13:00Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan35Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development...
► Artikel lesen
06.10.Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads153Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and...
► Artikel lesen
12.09.Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs)770Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for...
► Artikel lesen
13.08.Simris Group AB: Simris Group Interim Report January-june 2025143QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD...
► Artikel lesen
14.07.Simris Group AB: Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review133Simris Group AB (publ), through its subsidiary Simris Biologics GmbH, announces that the EU-based biopharmaceutical company with which it had signed a non-binding concept sheet for a potential antibody-drug...
► Artikel lesen
28.05.Simris Group AB: Bulletin from Simris Group AB's annual general meeting256Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 28 May 2025. Below follows a summary of the resolutions that were passed at the general meeting. Income...
► Artikel lesen
SIMRIS GROUP Aktie jetzt für 0€ handeln
14.05.Simris Group AB: Simris Group Interim Report January-march 2025292QUARTER 1, JANUARY - MARCH 2025Net revenue decreased by 69 percent to SEK 159k (519k).EBITDA improved by 30 percent to SEK -3 724k (-5 325k). EBIT/ operating result improved by 19 percent to SEK -7...
► Artikel lesen
26.02.Simris Group AB: Simris Group Year-end Report January-december 2024189QUARTER 4, OCTOBER - DECEMBER 2024Net revenue decreased by 63 percent to SEK 971k (2 657k).EBITDA improved by 41 percent to SEK -3 180k (-5 403k).EBIT/Operating result deteriorate by 6 percent to SEK...
► Artikel lesen
04.02.The observation status for Simris Group AB is removed300On October 24, 2024, the shares in Simris Group AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position. On...
► Artikel lesen
13.11.24Simris Group AB: Simris Group Interim Report January-September 2024302QUARTER 3, JULY - SEPTEMBER 2024Net revenue increased by 44 percent to SEK 766k (532k).EBITDA improved by 34 percent to SEK -2 971k (-4 525k).EBIT/Operating result improved by 18 percent to SEK -6 614k...
► Artikel lesen
10 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1